IP Library Granted Patent US 9,114,238
Granted Patent B2
US 9,114,238 · App. 12/148,180 · Granted Aug 25, 2015

Solvent-cast microprotrusion arrays containing active ingredient

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,114,238
App. No.
12/148,180
Granted
Aug 25, 2015
Kind
B2
Abstract

In an aspect of the invention, an array of microprotrusions is formed by providing a mold with cavities corresponding to the negative of the microprotrusions, casting atop the mold a first solution comprising a biocompatible material and a solvent, removing the solvent, casting a second solution atop the first cast solution, removing the solvent from the second solution, and demolding the resulting array from the mold. The first solution preferably contains an active ingredient.

Claims (59)

1. A microprotrusion array, comprising:

an approximately planar base and a plurality of microprotrusions, wherein the microprotrusions comprise at least a first and a second layer arranged roughly parallel to the plane of the base, the first and second layers formed of different polymers, the first layer is contained in a distal end of the microprotrusions and comprised of (i) a biodegradable polymer, (ii) a component to facilitate biodegradation selected from sugars, sugar alcohols, cyclodextrins and water-swellable polymers, and (iii) an active ingredient, wherein about 12-70 wt % of the first layer is comprised of the component to facilitate biodegradation.

2. The array of claim 1 , wherein the second layer is comprised of a polymer that is biodegradable.

3. The array of claim 1 , wherein at least one of the first and second layers adheres to human skin.

4. The array of claim 1 , wherein at least some of the microprotrusions detach from the base following insertion into skin.

5. The array of claim 4 , wherein the microprotrusions that detach after insertion provide diffusive channels for the active ingredient or a second active ingredient.

6. The array of claim 1 , wherein the rate at which portions of the microprotrusions degrade is dependent on the pH of the environment in which the portions of the microprotrusions find themselves following insertion.

7. The array of claim 6 , wherein the rate of degradation is greater at a pH of about 4 than at a pH of about 7.

8. The array of claim 6 , wherein the rate of degradation is greater at a pH of about 7 than at a pH of about 4.

9. The array of claim 1 , wherein the first layer comprises a composition which degrades at different rates at different temperatures in the range of about 25° C. to about 40° C.

10. The array of claim 9 , wherein the rate of degradation is greater at a temperature of 25° C. than at a temperature of 40° C.

11. The array of claim 9 , wherein the rate of degradation is greater at a temperature of 30° C. than at a temperature of 37° C.

12. The array of claim 1 , wherein at least the first layer comprises polyvinyl alcohol.

13. The array of claim 12 , wherein at least the first layer comprises polyvinyl alcohol which is 0-90% hydrolyzed.

14. The array of claim 1 , wherein at least the first layer comprises dextran.

15. The array of claim 1 , wherein at least the first layer comprises hydroxyethyl starch.

16. The array of claim 15 , wherein at least the first layer comprises hydroxyethyl starch which has a degree of substitution of 0-0.9.

17. The array of claim 1 , wherein the first layer comprises the sugar selected from dextrose, fructose, galactose, maltose, maltylose, iso-maltulose, mannose, lactose, lactulose, sucrose, and trehalose.

18. The array of claim 1 , wherein the first layer comprises the sugar alcohol selected from sorbitol, lactitol, malitol and mannitol.

19. The array of claim 1 , wherein at least the first layer comprises at least one antioxidant.

20. The array of claim 19 , wherein the antioxidant is chosen from the group consisting of methionine, cysteine, D-alpha tocopherol acetate, DL-alpha tocopherol, ascorbyl palmitate, ascorbic acid, butylated hydroxyanisole, butylated hydroxyquinone, hydroxycomarin, butylated hydroxytoluene, cephalin, ethyl gallate, propyl gallate, octyl gallate, lauryl gallate, propylhydroxybenzoate, trihydroxybutyrophenone, dimethylphenol, ditertbutylphenol, vitamin E, lecithin, and ethanolamine.

21. The array of claim 1 , wherein a layer of the first and second layers comprises cellulose acetate butyrate, cellulose acetate, cellulose acetate propionate, ethyl cellulose, nitrocellulose, hydroxypropyl methyl cellulose phthalate, a polyacrylate, or a polymethacrylate.

22. The array of claim 1 , wherein a layer of the first and second layers comprises a poly(hydroxyl alkanoate), poly(lactic acid), poly(glycolic acid), poly(lactic acid-co-glycolic acid), a polycaprolactone, or copolymers thereof.

23. The array of claim 1 , wherein the active ingredient comprises a polypeptide, a protein, or a nucleic acid.

24. The array of claim 1 , wherein the active ingredient comprises a vaccine.

25. The array of claim 1 , wherein the active ingredient comprises a therapeutic antibody.

26. The array of claim 1 , wherein the array achieves a skin penetration efficiency of at least about 80%.

27. The array of claim 1 , wherein the array achieves a skin penetration efficiency of at least about 90%.

28. The array of claim 27 , wherein the array achieves a skin penetration efficiency of at least about 95%.

29. The array of claim 1 , wherein an adhesiveness of at least one of the first and second layers increases with increasing moisture content over a range of moisture contents.

30. The array of claim 1 , wherein at least one of the first and second layers was produced by a process comprising solvent casting.

31. The array of claim 30 , wherein at least one of the first and second layers was produced by a process comprising solvent casting with a water based solvent with water content 50% or higher.

32. The array of claim 30 , wherein the second layer is produced by a process comprising solvent casting, and the first layer comprises at least one polymer or sugar which is not readily soluble in the solvent used to cast the second layer.

33. The array of claim 30 , wherein at least one of the first and second layers was produced by a process comprising solvent casting with a substantially non-aqueous solvent or an organic solvent or a mixture of solvents with non-aqueous content 50% or higher.

34. The array of claim 30 , wherein at least one of the first and second layers was produced by a process comprising solvent casting with a C 3 -C 8 alcohol as a solvent.

35. The array of claim 1 , wherein at least one microprotrusion has a cross sectional diameter in a plane parallel to that of the base which decreases as a function of the distance of the plane parallel from the base in such a way that the cross sectional diameter decreases more rapidly near the base than further away from it.

36. The array of claim 35 , wherein a portion of at least one microprotrusion does not penetrate the skin when the microprotrusion is in use.

37. The array of claim 1 , wherein at least one of the first and second layers comprises starches, 2-hydroxyethylstarches, hetastarch, dextran, pH sensitive hydroxypropyl methylcellulose, collagen and its derivatives, hyaluronic acid and its derivatives or polyphosphazene.

38. The array of claim 1 , wherein at least one of the first and second layers comprises polystyrene.

39. The array of claim 1 , wherein at least one of the first and second layers comprises an antimicrobial.

40. The array of claim 39 , wherein the antimicrobial is chosen from the group consisting of benzalkonium chloride, benzyl alcohol, chlorbutanol, meta cresol, esters of hydroxyl benzoic acid, phenol, and thimerosal.

41. The array of claim 1 , wherein the first layer contains only a portion of the microprojections.

42. The array of claim 1 , wherein the first layer is more readily degradable in the human body than the second layer.

43. The array of claim 1 , wherein the second layer contains no active ingredient or a lower concentration of active ingredient than the first layer.

44. The array of claim 1 , wherein the first layer controls the rate at which active ingredient is released from the microprojections.

45. The array of claim 1 , wherein the first layer comprises a polymer selected from the group consisting of poly(lactic acid), poly(glycolic acid), poly(lactic acid-co-glycolic acid), poly(caprolactone), polyanhydrides, polyamines, polyesteramides, polyorthoesters, polydioxanones, polyacetals, polyketals, polycarbonates, polyphosphoesters, polyorthocarbonates, polyphosphazenes, poly(malic acid), poly(amino acids), hydroxycellulose, polyphosphoesters, poly(hydroxyl alkonates), polysaccharides, chitin, and copolymers, terpolymers and mixtures thereof.

46. The array of claim 1 , wherein the array comprises at least one polymer with a molecular weight of at least about 10 kD.

47. The array of claim 1 , wherein the array comprises at least one polymer with a molecular weight of at least about 22 kD.

48. The array of claim 1 , wherein a boundary between two adjacent layers of the at least first and second layers exhibits a meniscus.

49. The array of claim 1 , wherein the active ingredient comprises parathyroid hormone.

50. The array of claim 1 , further comprising an antibacterial agent selected from the group consisting of benzalkonium chloride, benzyl alcohol, chlorbutanol, meta cresol, esters of hydroxyl benzoic acid, phenol, and thimerosal.

51. The array of claim 1 , wherein the second layer contains the entire base and a portion of the microprotrusions.

52. The array of claim 51 , wherein the second layer is comprised of a biodegradable polymer selected from poly(lactic acid) (PLA), poly(glycolic acid) (PGA) and poly(lactic acid-co-glycolic acid)s (PLGAs).

53. The array of claim 52 , wherein the biodegradable polymer in the first layer is selected from dextran and tetrastarch.

54. The array of claim 1 , wherein the number of microprotrusions in the array is at least about 100.

55. The array of claim 1 , wherein the number of microprotrusions in the array is at least about 50 per cm 2 of base area.

56. The array of claim 1 , wherein the biodegradable polymer in the first layer is selected from dextran and tetrastarch.

57. The array of claim 1 , wherein the biodegradable polymer in the first layer is dextran, the component to facilitate biodegradation is sorbitol, and the active ingredient is parathyroid hormone.

58. The array of claim 1 , wherein about 12-62.8 wt % of the first layer is comprised of the component to facilitate biodegradation.

Assignments (19)
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NUMBER PREVIOUSLY RECORDED AT REEL: 61852 FRAME: 207. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 30, 2025
From: CORIUM, INC.
To: CORIUM PHARMA SOLUTIONS, INC.
Reel/Frame 071915/0691 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 24, 2022
From: CORIUM, INC.
To: CORIUM PHARMA SOLUTIONS, INC.
Reel/Frame 062760/0731 →
RELEASE OF SECURITY INTEREST Recorded Oct 19, 2022
From: HERCULES CAPITAL, INC., AS AGENT
To: CORIUM, INC.
Reel/Frame 061713/0557 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 028927/0782 Recorded Oct 18, 2022
From: SILICON VALLEY BANK
To: CORIUM, INC., FORMERLY CORIUM INTERNATIONAL, INC.
Reel/Frame 062257/0614 →
SECURITY INTEREST Recorded Oct 17, 2022
From: CORIUM PHARMA SOLUTIONS, INC.
To: SILICON VALLEY BANK, AS ADMINISTRATIVE AGENT
Reel/Frame 061689/0581 →
RELEASE OF SECURITY INTEREST Recorded Oct 17, 2022
From: HERCULES CAPITAL, INC.
To: CORIUM, INC.
Reel/Frame 061687/0281 →
CHANGE OF NAME Recorded Oct 14, 2022
From: CORIUM, INC.
To: CORIUM PHARMA SOLUTIONS, INC.
Reel/Frame 061852/0207 →
SECURITY INTEREST Recorded Sep 24, 2021
From: CORIUM, INC.
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 057597/0907 →
CHANGE OF NAME Recorded Apr 9, 2019
From: CORIUM INTERNATIONAL, INC.
To: CORIUM, INC.
Reel/Frame 048841/0324 →
RELEASE OF SECURITY INTEREST Recorded Mar 6, 2018
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "B" (CAYMAN) L.P.; CAPITAL ROYALTY PARTNERS II (CAYMAN) L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: CORIUM INTERNATIONAL, INC.
Reel/Frame 046909/0855 →
RELEASE OF SECURITY INTEREST Recorded Mar 6, 2018
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "B" (CAYMAN) L.P.; CAPITAL ROYALTY PARTNERS II (CAYMAN) L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: CORIUM INTERNATIONAL, INC.
Reel/Frame 045513/0686 →
RELEASE OF SECURITY INTEREST Recorded Nov 27, 2017
From: SILICON VALLEY BANK
To: CORIUM INTERNATIONAL, INC.
Reel/Frame 044810/0026 →
SECURITY INTEREST Recorded Dec 4, 2014
From: CORIUM INTERNATIONAL, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II ? PARALLEL FUND ?A? L.P.; CAPITAL ROYALTY PARTNERS II ? PARALLEL FUND ?B? (CAYMAN) L.P.; CAPITAL ROYALTY PARTNERS II (CAYMAN) L.P.
Reel/Frame 034535/0238 →
SECURITY AGREEMENT Recorded Sep 10, 2012
From: CORIUM INTERNATIONAL, INC.
To: SILICON VALLEY BANK
Reel/Frame 028927/0782 →
SECURITY AGREEMENT Recorded Sep 4, 2012
From: CORIUM INTERNATIONAL, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 028895/0961 →
RELEASE OF SECURITY INTEREST Recorded Aug 30, 2012
From: OXFORD FINANCE LLC
To: CORIUM INTERNATIONAL, INC.
Reel/Frame 028884/0179 →
SECURITY AGREEMENT Recorded Dec 20, 2011
From: CORIUM INTERNATIONAL, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 027422/0717 →
SECURITY AGREEMENT Recorded May 5, 2009
From: CORIUM INTERNATIONAL, INC.
To: SILICON VALLEY BANK
Reel/Frame 022634/0119 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2008
From: SINGH, PARMINDER; WORSHAM, ROBERT WADE; TRAUTMAN, JOSEPH C.; BAYRAMOV, DANIR; BOWERS, DANNY LEE; KLEMM, ANDY; KLEMM, STEVEN RICHARD; CHEN, GUOHUA
To: CORIUM INTERNATIONAL, INC.
Reel/Frame 021274/0958 →